Nasdaq:VINC

Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down ActivitiesVincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities

Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities

SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated…

4 weeks ago
Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic AlternativesVincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives

Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives

SAN MATEO, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that the previously signed…

2 months ago
Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqorys TROP2 Antibody Drug Conjugate, OQY-3258Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqorys TROP2 Antibody Drug Conjugate, OQY-3258

Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqorys TROP2 Antibody Drug Conjugate, OQY-3258

SAN MATEO, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address…

3 months ago
Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address…

4 months ago
Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address…

4 months ago
Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address…

4 months ago